Latest News

Jonathan W. Weinsaft, MD, chief of cardiology and professor of medicine at Weill Cornell Medical College
Working to Enable Gene Therapy for Cardiovascular Disease

May 18th 2024

Jonathan W. Weinsaft, MD, chief of cardiology and professor of medicine at Weill Cornell Medical College, discussed research the center is doing in the space.

Faraz Ali, MBA, the chief executive officer of Tenaya Therapeutics
Faraz Ali, MBA, on Trends in Precision Medicine for Cardiovascular Disease

May 18th 2024

Harish Venkatesh, BS candidate, Department of Regulatory and Quality Sciences, University of Southern California, Los Angeles, California
Cell and Gene Therapy Trials Face Disproportionate Amount of Clinical Holds

May 17th 2024

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – May 17, 2024

May 17th 2024

Lawrence R. Lustig, MD, the chair of the Department of Otolaryngology—Head and Neck Surgery at Columbia University College of Physicians
Otoferlin-Related Hearing Loss Gene Therapy May Open the Door to Gene Therapies for Other Types of Hearing Loss

May 17th 2024

Video Interviews

Conference Coverage

View All
Faraz Ali, MBA, the chief executive officer of Tenaya Therapeutics
Faraz Ali, MBA, on Trends in Precision Medicine for Cardiovascular Disease

May 18th 2024

Harish Venkatesh, BS candidate, Department of Regulatory and Quality Sciences, University of Southern California, Los Angeles, California
Cell and Gene Therapy Trials Face Disproportionate Amount of Clinical Holds

May 17th 2024

Lawrence R. Lustig, MD, the chair of the Department of Otolaryngology—Head and Neck Surgery at Columbia University College of Physicians
Otoferlin-Related Hearing Loss Gene Therapy May Open the Door to Gene Therapies for Other Types of Hearing Loss

May 17th 2024

Faraz Ali, MBA, the chief executive officer of Tenaya Therapeutics
Faraz Ali, MBA, on Adding Gene Editing Programs to Tenaya’s Cardiovascular Disease Pipeline

May 16th 2024

All News

© 2024 MJH Life Sciences

All rights reserved.